home / stock / hbp / hbp news

HBP News and Press, Huttig Building Products Inc. From 03/15/19

Stock Information
Company Name: Huttig Building Products Inc.
Stock Symbol: HBP
Market: NASDAQ
Website: huttig.com
Menu
HBP HBP Quote HBP Short HBP News HBP Articles HBP Message Board
Get HBP Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP - Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update

RICHMOND HILL, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has c...
HBP - Microcaps mostly among midday movers

Gainers:  VivoPower International (NASDAQ: VVPR ) +52% . ENDRA Life Sciences (NASDAQ: NDRA ) +41% . Leap Therapeutics (NASDAQ: LPTX ) +31% . Stitch Fix (NASDAQ: SFIX ) +30% . Seelos Therapeutics (NASDAQ: SEEL ) +26% . Key Energy Services (NYSE: KEG ) +24% . Chaparral Energy (NYS...

HBP - Helix BioPharma Corp.: First Patient Dosed in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin

RICHMOND HILL, Ontario, March 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce...

HBP - Huttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q4 2018 Results - Earnings Call Transcript

Huttig Building Products, Inc. (HBP) Q4 2018 Earnings Conference Call March 5, 2019 11:00 AM Company Participants Jon Vrabely - President, Chief Executive Officer and Director Philip Keipp - Chief Financial Officer and Executive Vice President Bob Furio - Executive Vice President...
HBP - Huttig Building Products reports Q4 results

Huttig Building Products (NYSEMKT: HBP ): Q4 GAAP EPS of -$0.27. More news on: Huttig Building Products, Inc., Earnings news and commentary, , Read more ...

HBP - Huttig Building Products, Inc. Announces Fourth Quarter and Full Year 2018 Results

Fourth Quarter and Full Year 2018 Highlights: Net sales of $196.2 million and $839.6 million, respectively Sales growth of 9.5% and 11.5%, respectively Net loss of $7.3 million and $6.4 million, respectively Net reduction in debt of $30.1 million in the fourth quarter of 201...

HBP - Helix BioPharma Corp. and Moffitt Cancer Center to Present at the AACR Annual Meeting 2019 in Atlanta

RICHMOND HILL, Ontario, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce ...
HBP - Huttig Building Products, Inc. Schedules Fourth Quarter and Year Ended December 31, 2018 Earnings Call

ST. LOUIS, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation’s largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its fourth quart...

HBP - Helix BioPharma Corp. Provides Clinical Development and Strategic Corporate Update

RICHMOND HILL, Ontario, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer today provides an update...

HBP - Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced a change...
Previous 10 Next 10